Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer

Lingjiao Zou, Qiuping Xiang, Xiaoqian Xue, Cheng Zhang, Chenchang Li, Chao Wang, Qiu Li, Rui Wang, Shuang Wu, Yulai Zhou,

Acta Pharmacologica Sinica · 2019 · 47 citations · 40 references

DOIFull text

Open access

Concepts

References

40